Shionogi’s flu drug wins green light in Japan, but U.S. approval not likely until 2019

As one of the worst flu seasons in years ravages the Northern Hemisphere, a powerful flu drug developed by Shionogi has been approved in Japan under a fast-track process. However, the U.S. may not see it before next winter.Original Article